HPTN Publications

Kafulafula G, Mwatha A, Chen YQ, Aboud S, Martinson F, Hoffman I, Fawzi W, Read JS, Valentine M, Mwinga K, Goldenberg R, Taha TE . Intrapartum antibiotic exposure and early neonatal, morbidity, and mortality in Africa. Pediatrics. 2009, 124: e137-44

Kajeepeta S, MacPhail C, Selin A, Gómez-Olivé FX, Gottert A, Kahn K, Hughes JP, Pettifor A . Gender attitudes and associations with sexual risk behaviors and outcomes among young South African women (HPTN 068).

Kaleebu P, Njai HF, Wang L, Jones N, Ssewanyana I, Richardson P, Kintu K, Emel L, Musoke P, Fowler MG, Ou SS, Jackson JB, Guay L, Andrew P, Baglyos L, Cao H; HPTN 027 protocol team . Immunogenicity of ALVAC-HIV vCP1521 in Infants of
HIV-1–Infected Women in Uganda (HPTN 027): The First
Pediatric HIV Vaccine Trial in Africa. J Acquir Immune Defic Syndr. 2014, 65: 268-77

Kalichman SC, Zohren L, Eaton LA . Setting the bar high or setting up to fail? Interpretations and implications of the EXPLORE Study (HPTN 015). AIDS Behav. 2014, 18: 625-33

Kapadia SN, Wu C, Mayer KH, Wilkin TJ, Amico KR, Landovitz RJ, Andrade A, Chen YQ, Chege W, McCauley M, Gulick RM, Schackman BR . No change in health-related quality of life for at-risk U.S. women and men starting HIV pre-exposure prophylaxis (PrEP): Findings from HPTN 069/ACTG A5305. PLoS One. 2018, 13: e0206577

Kapiga S, Kelly C, Weiss S, Daley T, Peterson L, Leburg C, Ramjee G . Risk factors for incidence of sexually transmitted infections among women in South Africa, Tanzania, and Zambia: results from HPTN 055 study. Sex Transm Dis. 2009, 36: 199-206 PMID:19265734

Kapina M, Reid C, Roman K, Cyrus-Cameron E, Kwiecien A, Weiss S, Vermund SH . HIV Incidence Rates and Risk Factors for Urban Women in Zambia: Preparing for a Microbicide Clinical Trial. Sex Transm Dis. 2009, 36: 129-33

Karim QA, Baxter C, Karim SA . Topical microbicides--what's new?. J Acquir Immune Defic Syndr. 2013, 63: S144-9